Orofacial Pain Insider: 3rd-molar surgery patients open to relief but not cost of bupivacaine

Busch Melissa 2 Crop

Dear Orofacial Pain Insider,

Patients want to receive the long-acting local anesthetic liposomal bupivacaine to help manage pain after third-molar surgery, but few are willing to pay for it themselves, according to study findings published earlier this month in the Journal of Oral and Maxillofacial Surgery. Read our Insider Exclusive.

In other news, researchers at the Pain Research Center at New York University’s College of Dentistry recently developed a gene therapy that treats chronic pain, according to a recently published study.

Additionally, patients who experience trauma, such as wisdom teeth extractions, may develop temporomandibular disorders, according to a study published in Cranio.

Did you know that older adults experience a nearly 60% reduction in dentine hypersensitivity when silver diamine fluoride (SDF) was applied to the root surfaces of their teeth? It is believed to be the first clinical trial investigating the short- and long-term desensitizing effect of SDF on hypersensitive teeth due to exposed root surfaces in older adults.

Finally, a healthy woman developed the very rare complication of traumatic myositis ossificans of the temporal muscle attachment after receiving an injection of local anesthesia near that area for root canal treatment, according to a recent case report.

Page 1 of 182
Next Page